Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 1/2010

01-12-2010 | Original Article

Lower BMI cutoff for assessing the prevalence of metabolic syndrome in Thai population

Authors: Apilak Worachartcheewan, Chanin Nantasenamat, Chartchalerm Isarankura-Na-Ayudhya, Phannee Pidetcha, Virapong Prachayasittikul

Published in: Acta Diabetologica | Special Issue 1/2010

Login to get access

Abstract

This article investigates the prevalence of metabolic syndrome (MS) and the benefits of lowered body mass index (BMI) cutoff point for assessing MS prevalence in a large, nationally representative population sample comprising of 15,365 Thai adults from metropolitan Bangkok who received annual checkup. Prevalence of MS was characterized using the International Diabetes Federation criteria and BMI ≥25 kg/m2 as cutoff revealed that 26.63% of male and 14.90% of female subjects had MS and the prevalence was age dependent. Traditional BMI cutoff of ≥30 kg/m2 underestimated MS prevalence in Thai population while BMI ≥25 kg/m2 was found to be a suitable solution. Common combinations of MS components were identified in order to find common occurrences that may be implicated in the development of diabetes and/or cardiovascular diseases.
Literature
1.
Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109:433–438CrossRefPubMed
2.
Zimmet P, Alberti KG, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782–787CrossRefPubMed
3.
Mackay J, Mensah G (2004) Atlas of heart disease and stroke. World Health Organization, Geneva
4.
Alberti K, Zimmet P (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO consultation. Diabet Med 15:539–553CrossRefPubMed
5.
Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16:442–443CrossRefPubMed
6.
Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) (2001) JAMA 285:2486–2497
7.
8.
Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome—a new world-wild definition. A consensus statement from the International Diabetes Federation. Diabet Med 23:469–480CrossRefPubMed
9.
Tan CE, Ma S, Wai D, Chew SK, Tai ES (2004) Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabet Care 27:1182–1186CrossRef
10.
Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome—a new worldwide definition. Lancet 366:1059–1062
11.
Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J (2005) The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 12:295–300PubMed
12.
Ryan MC, Fenster Farin HM, Abbasi F, Reaven GM (2008) Comparison of waist circumference versus body mass index in diagnosing metabolic syndrome and identifying apparently healthy subjects at increased risk of cardiovascular disease. Am J Cardiol 102:40–46CrossRefPubMed
13.
Anuurad E, Shiwaku K, Nogi A, Kitajima K, Enkhmaa B, Shimono K, Yamane Y (2003) The new BMI criteria for Asians by the regional office for the western pacific region of WHO are suitable for screening of overweight to prevent metabolic syndrome in elder Japanese workers. J Occup Health 45:335–343CrossRefPubMed
14.
World Health Organization, International Association for the Study of Obesity, International Obesity Taskforce (2000) The Asia-Pacific perspective: redefining obesity and its treatment. Health Communications, Sydney
15.
Amos A, McCarty D, Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 14(Suppl 5):S1–S85PubMed
16.
17.
18.
Wibulpolprasert S, Sirilak S, Ekachampaka P, Wattanamano N, Taverat R (2007) Thailand Health Profile Report 2005–2007. Bureau of Policy and Strategy, Ministry of Public Health, Thailand
19.
Neison FGP (1844) On a method recently proposed for conducting inquiries into the comparative sanatory condition of various districts. Lond J R Stat Soc 7:40–68CrossRef
20.
21.
Ford ES, Giles WH, Mokdad AH (2004) Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 27:2444–2449CrossRefPubMed
22.
Shiwaku K, Anuurad E, Enkhmaa B, Kitajima K, Yamane Y (2004) Appropriate BMI for Asian populations. Lancet 363:1077CrossRefPubMed
23.
WHO expert consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163CrossRef
24.
Ko GT, Tang J, Chan JC, Sung R, Wu MM, Wai HP, Chen R (2001) Lower BMI cutoff value to define obesity in Hong Kong Chinese: an analysis based on body fat assessment by bioelectrical impedance. Br J Nutr 85:239–242CrossRefPubMed
25.
Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC (2004) Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 79:31–39PubMed
26.
Oh SW, Shin SA, Yun YH, Yoo T, Huh BY (2004) Cut-off point of BMI and obesity-related comorbidities and mortality in middle-aged Koreans. Obes Res 12:2031–2040CrossRefPubMed
27.
Morimoto A, Nishimura R, Suzuki N, Matsudaira T, Taki K, Tsujino D, Miyashita Y, Ebara F, Ishikawa S, Tajima N (2008) Low prevalence of metabolic syndrome and its components in rural Japan. Tohoku J Exp Med 216:69–75CrossRefPubMed
28.
Stone MA, Williams L, Chatterjee S, Davies MJ, Khunti K (2008) Ethnic differences in body composition in adolescents. Prim Care Diabetes 2:55–57CrossRefPubMed
Metadata
Title
Lower BMI cutoff for assessing the prevalence of metabolic syndrome in Thai population
Authors
Apilak Worachartcheewan
Chanin Nantasenamat
Chartchalerm Isarankura-Na-Ayudhya
Phannee Pidetcha
Virapong Prachayasittikul
Publication date
01-12-2010
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue Special Issue 1/2010
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0137-0

Other articles of this Special Issue 1/2010

Acta Diabetologica 1/2010 Go to the issue

Original Article

Failure to metformin and insulin secretagogue monotherapy: an observational cohort study

Original Article

Influence of iron metabolism indices on glycated haemoglobin but not glycated albumin levels in premenopausal women

Original Article

Antihyperglycemic and antihyperlipidemic effects of Ziziphus vulgaris L. onreptozocin-induced diabetic adult male Wistar rats

Original Article

Variation in the checkpoint kinase 2 gene is associated with type 2 diabetes in multiple populations

Original Article

How increased VEGF induces glomerular hyperpermeability: a potential signaling pathway of Rac1 activation

Original Article

Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits